Unichem gets USFDA nod for generic version of tolterodine tartrate tablets

Unichem Laboratories. Photo: UnichemLabs.com

Unichem Laboratories Ltd on Thursday said it has received approval from the US health regulator to market its generic version of tolterodine tartrate tablets used in the treatment of overactive urinary bladder.

The approval by the US Food and Drug Administration (USFDA) to market tolterodine tartrate tablets is for strengths of 1 mg and 2 mg, Unichem Laboratories said in a regulatory filing.

The tolterodine tartrate tablets are generic versions of Pfizer Inc's DETROL tablets, it added.

The tablets are indicated for treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

The product will be commercialised from Unichem's Goa plant, the company said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel